Antiplatelets, statins, and cilostazol in peripheral artery disease

Medical therapy is the responsibility of the interventionalist

Vishesh Kumar, David P. Slovut

Research output: Contribution to journalArticle

Abstract

Peripheral artery disease (PAD) is a common condition encountered in primary care and subspecialty clinics. Despite guidelines recommending antiplatelet agents, statins, and in some cases cilostazol, many patients with PAD are not receiving appropriate medications. Interventionalists who evaluate and treat these patients have a unique opportunity to prescribe appropriate cardioprotective medications, and to educate the primary care provider. In this article we will review guidelines for prescribing antiplatelet agents (aspirin and clopidogrel), statins, and cilostazol in patients with PAD; review evidence behind the guidelines; and present a "report card" of healthcare provider compliance with these guidelines. We will also describe some of the barriers that reduce clinician compliance with guidelines and present some strategies to overcome these barriers.

Original languageEnglish (US)
Pages (from-to)37-44
Number of pages8
JournalVascular Disease Management
Volume10
Issue number2
StatePublished - 2013

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Peripheral Arterial Disease
Guidelines
clopidogrel
Platelet Aggregation Inhibitors
Primary Health Care
Therapeutics
Health Personnel
Aspirin
cilostazol

Keywords

  • Medical treatment of peripheral artery disease
  • Peripheral artery disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{1adcf7a67ed34f5693018c5b1b80352e,
title = "Antiplatelets, statins, and cilostazol in peripheral artery disease: Medical therapy is the responsibility of the interventionalist",
abstract = "Peripheral artery disease (PAD) is a common condition encountered in primary care and subspecialty clinics. Despite guidelines recommending antiplatelet agents, statins, and in some cases cilostazol, many patients with PAD are not receiving appropriate medications. Interventionalists who evaluate and treat these patients have a unique opportunity to prescribe appropriate cardioprotective medications, and to educate the primary care provider. In this article we will review guidelines for prescribing antiplatelet agents (aspirin and clopidogrel), statins, and cilostazol in patients with PAD; review evidence behind the guidelines; and present a {"}report card{"} of healthcare provider compliance with these guidelines. We will also describe some of the barriers that reduce clinician compliance with guidelines and present some strategies to overcome these barriers.",
keywords = "Medical treatment of peripheral artery disease, Peripheral artery disease",
author = "Vishesh Kumar and Slovut, {David P.}",
year = "2013",
language = "English (US)",
volume = "10",
pages = "37--44",
journal = "Vascular Disease Management",
issn = "1553-8036",
publisher = "HMP Communications",
number = "2",

}

TY - JOUR

T1 - Antiplatelets, statins, and cilostazol in peripheral artery disease

T2 - Medical therapy is the responsibility of the interventionalist

AU - Kumar, Vishesh

AU - Slovut, David P.

PY - 2013

Y1 - 2013

N2 - Peripheral artery disease (PAD) is a common condition encountered in primary care and subspecialty clinics. Despite guidelines recommending antiplatelet agents, statins, and in some cases cilostazol, many patients with PAD are not receiving appropriate medications. Interventionalists who evaluate and treat these patients have a unique opportunity to prescribe appropriate cardioprotective medications, and to educate the primary care provider. In this article we will review guidelines for prescribing antiplatelet agents (aspirin and clopidogrel), statins, and cilostazol in patients with PAD; review evidence behind the guidelines; and present a "report card" of healthcare provider compliance with these guidelines. We will also describe some of the barriers that reduce clinician compliance with guidelines and present some strategies to overcome these barriers.

AB - Peripheral artery disease (PAD) is a common condition encountered in primary care and subspecialty clinics. Despite guidelines recommending antiplatelet agents, statins, and in some cases cilostazol, many patients with PAD are not receiving appropriate medications. Interventionalists who evaluate and treat these patients have a unique opportunity to prescribe appropriate cardioprotective medications, and to educate the primary care provider. In this article we will review guidelines for prescribing antiplatelet agents (aspirin and clopidogrel), statins, and cilostazol in patients with PAD; review evidence behind the guidelines; and present a "report card" of healthcare provider compliance with these guidelines. We will also describe some of the barriers that reduce clinician compliance with guidelines and present some strategies to overcome these barriers.

KW - Medical treatment of peripheral artery disease

KW - Peripheral artery disease

UR - http://www.scopus.com/inward/record.url?scp=84903516957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903516957&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 37

EP - 44

JO - Vascular Disease Management

JF - Vascular Disease Management

SN - 1553-8036

IS - 2

ER -